TFThayssa Gomes Farias

Thayssa Gomes Farias

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Thayssa Gomes Farias has a total of 27 co-authors. Here are the top co-authors by number of shared publications:

  • Andre Luiz Mencalha

    Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    5 shared publications
  • Adenilson de Souza da Fonseca

    Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcântara Gomes Universidade do Estado do Rio de Janeiro Rio de Janeiro Brazil

    4 shared publications
  • Márcia Soares dos Santos

    Departamento de Biofísica e Biometria Instituto de Biologia Roberto Alcântara Gomes, Universidade do Estado do Rio de Janeiro, Vila Isabel, Rio de Janeiro, Brazil

    4 shared publications
  • Adenilson de Souza da Fonseca

    Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    3 shared publications
  • Andre Luiz Mencalha

    Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Boulevard Vinte e Oito de Setembro, 87, fundos, Vila Isabel, Rio de Janeiro, 20551030, Brazil

    3 shared publications
  • Juliana Alves Rodrigues

    Departamento de Biofísica e Biometria, Instituto de Biologia Roberto Alcantara Gomes, Universidade do Estado do Rio de Janeiro, Rio de Janeiro, Brazil

    3 shared publications

Latest Publications

  • Photobiomodulation by infrared radiation on hallmarks of cancer

    by da Silva Ferreira, Ana Caroline, Thayssa Gomes Farias, Cardoso Borges, Ana Julia, Marcelle Abreu da Silva, Barreto Pires, Bruno Ricardo, Andre Luiz Mencalha, Adenilson de Souza da Fonseca

    Photobiomodulation (PBM) is a therapeutic technique that utilizes non-ionizing radiation, such as infrared radiation, which is capable of stimulating or inhibiting biological processes. Cancer is characterized by uncontrolled cell growth and proliferation in any body structure, allowing it to invade other tissues. Cancer exhibits distinct biological characteristics, the so-called hallmarks of cancer. Despite the therapeutic benefits of PBM, and cancers affect millions of people worldwide, the mechanisms involved in PBM, as those induced by infrared A radiation, on cancer are not yet fully elucidated. Thus, we aimed to review the effects of PBM induced by infrared radiation on the hallmarks of cancer. For this, studies on the effects of PBM induced by infrared A radiation on in vitro and in vivo experimental models of cancer were accessed via MEDLINE/PubMed. The data accessed showed that effects of PBM induced by infrared A radiation were evaluated on four hallmarks of cancer (sustaining proliferative signaling, evading growth suppressors, genomic instability and mutation, and resisting cell death) but not on the other ten ones (enabling replicative immortality, non-mutational epigenetic reprogramming, avoiding immune destruction, tumor-promoting inflammation, polymorphic microbiomes, activating invasion and metastasis, inducing or accessing vasculature, senescent cells, deregulation cellular energetics, unlocking phenotypic plasticity). Thus, considering the therapeutic benefits of PBM, evaluation of the effects of PBM on the hallmarks of cancer can also bring such benefits to oncologic patients.


  • Could photobiomodulation be used for treatment of rosacea?

    by Boaretto Netto, José Carlos, Cardoso Borges, Ana Julia, Thayssa Gomes Farias, Adenilson de Souza da Fonseca

    Rosacea is a chronic inflammatory disease characterized by facial skin lesions, including flushing, persistent erythema, papules, telangiectasia, and phymatous changes, affecting 5.5% of the world’s population. Rosacea causes disfigurement and emotional ramifications and affects quality of life. The pathophysiology of this disease has yet to be understood, and new therapies are necessary. Photobiomodulation has been used to treat dermatological diseases and various conditions, such as inflammatory processes and pain relief. Thus, this study aimed to review studies on PBM for rosacea treatment, summarizing the radiation sources and subject features and reporting the main results. Scientific articles were accessed by PubMed, using keywords related to rosacea and photobiomodulation. Data on irradiation conditions, patient features, experimental models, and results obtained were assessed. The data analysis allowed to list the conditions for applying photobiomodulation that could lead to therapeutic effects, safety, and efficacy in treating the rosacea. Based on clinical and experimental studies accessed, photobiomodulation could decrease rosacea hallmarks and symptoms by decreasing of pro-inflammatory factor expression, inflammatory infiltration and immune cells, and promoting extracellular matrix remodeling. However, due to few studies available on the application of photobiomodulation in the treatment of rosacea, studies based on experimental and clinical models are necessary to better understand the mechanisms of action of this therapy, efficacy, and validation in the treatment of rosacea.


  • Effects of photobiomodulation in mitochondrial quantity, biogenesis and mitophagy-associated genes in breast cancer cells

    by Larissa Alexsandra da Silva Neto Trajano, Priscyanne Barreto Siqueira, Daphne Pinheiro, Thayssa Gomes Farias, Márcia Soares dos Santos, Bruno Ricardo Barreto Pires, Adenilson de Souza da Fonseca, Andre Luiz Mencalha

    In this article, we aim to evaluate the effects of photobiomodulation on mitochondria quantity, biogenesis, and mitophagy-associated genes in breast cancer (BC) cells. Both models were irradiated with a low-power infrared laser (880 nm, 150 mW) and amber LED (617 nm, 1500 mW), alone or simultaneously. We evaluated the mRNA expression of PINK1 and PGC-1α genes, and the mitochondrial number was assessed based on the ratio of mitochondrial DNA/genomic DNA (mtDNA/gDNA). No significant difference was observed in the mtDNA/gDNA ratio comparing the low-power infrared laser (LPIL) and LED-irradiated groups to their control counterparts. Similarly, no difference was observed in the mRNA levels of PINK1 and PGC-1α of the irradiated group with an LPIL and LED alone or in combination. In conclusion, PBM with LPIL and LED did not alter the mtDNA/gDNA ratio nor modulate the mRNA levels of the genes related to mitophagy and biogenesis in BC cells.


  • Low-power red laser and blue LED modulate telomere maintenance and length in human breast cancer cells

    by Thayssa Gomes Farias, Márcia Soares dos Santos, Andre Luiz Mencalha, Adenilson de Souza da Fonseca

    Cancer cells have the ability to undergo an unlimited number of cell divisions, which gives them immortality. Thus, the cancer cell can extend the length of its telomeres, allowing these cells to divide unlimitedly and avoid entering the state of senescence or cellular apoptosis. One of the main effects of photobiomodulation (PBM) is the increase in the production of adenosine triphosphate (ATP) and free radicals, mainly reactive oxygen species (ROS). Existent data indicates that high levels of ROS can cause shortening and dysfunctional telomeres. Therefore, a better understanding of the effects induced by PBM on cancer cell telomere maintenance is needed. This work aimed to evaluate the effects of low-power red laser (658 nm) and blue LED (470 nm) on the TRF1 and TRF2 mRNA levels and telomere length in human breast cancer cells. MCF-7 and MDA-MB-231 cells were irradiated with a low-power red laser (69 J cm-2, 0.77 W/cm-2) and blue LED (482 J cm-2, 5.35 W/cm-2), alone or in combination, and the relative mRNA levels of the genes and telomere length were assessed by quantitative reverse transcription polymerase chain reaction. The results suggested that exposure to certain red laser and blue LED fluences decreased the TRF1 and TRF2 mRNA levels in both human breast cancer cells. Telomere length was increased in MCF-7 cells after exposure to red laser and blue LED. However, telomere length in MDA-MB-231 was shortened after exposure to red laser and blue LED at fluences evaluated. Our research suggests that photobiomodulation induced by red laser and low-power blue LED could alter telomere maintenance and length.


  • Open Access

    Correction to: Effects of low-power red laser and blue LED on mRNA levels from DNA repair genes in human breast cancer cells

    by Thayssa Gomes Farias, Juliana Alves Rodrigues, Márcia Soares dos Santos, Andre Luiz Mencalha, Adenilson de Souza da Fonseca


  • Effects of low‑power red laser and blue LED on mRNA levels from DNA repair genes in human breast cancer cells

    by Thayssa Gomes Farias, Juliana Alves Rodrigues, Márcia Soares dos Santos, Andre Luiz Mencalha, Adenilson de Souza da Fonseca

    Photobiomodulation (PBM) induced by non-ionizing radiations emitted from low-power lasers and light-emitting diodes (LEDs) has been used for various therapeutic purposes due to its molecular, cellular, and systemic effects. At the molecular level, experimental data have suggested that PBM modulates base excision repair (BER), which is responsible for restoring DNA damage. There is a relationship between the misfunction of the BER DNA repair pathway and the development of tumors, including breast cancer. However, the effects of PBM on cancer cells have been controversial. Breast cancer (BC) is the main public health problem in the world and is the most diagnosed type of cancer among women worldwide. Therefore, the evaluation of new strategies, such as PBM, could increase knowledge about BC and improve therapies against BC. Thus, this work aims to evaluate the effects of low-power red laser (658 nm) and blue LED (470 nm) on the mRNA levels from BER genes in human breast cancer cells. MCF-7 and MDA-MB-231 cells were irradiated with a low-power red laser (69 J cm-2, 0.77 W cm-2) and blue LED (482 J cm-2, 5.35 W cm-2), alone or in combination, and the relative mRNA levels of the APTX, PolB, and PCNA genes were assessed by reverse transcription-quantitative polymerase chain reaction. The results suggested that exposure to low-power red laser and blue LED decreased the mRNA levels from APTX, PolB, and PCNA genes in human breast cancer cells. Our research shows that photobiomodulation induced by low-power red laser and blue LED decreases the mRNA levels of repair genes from the base excision repair pathway in MCF-7 and MDA-MB-231 cells.


  • The APE1/REF-1 and the hallmarks of cancer

    by Priscyanne Barreto Siqueira, Mariana Moreno de Sousa Rodrigues, Ísis Salviano Soares de Amorim, Thayssa Gomes da Silva, Matheus da Silva Oliveira, Juliana Alves Rodrigues, Adenilson de Souza da Fonseca, Andre Luiz Mencalha

    APE1/REF-1 (apurinic/apyrimidinic endonuclease 1 / redox factor-1) is a protein with two domains, with endonuclease function and redox activity. Its main activity described is acting in DNA repair by base excision repair (BER) pathway, which restores DNA damage caused by oxidation, alkylation, and single-strand breaks. In contrast, the APE1 redox domain is responsible for regulating transcription factors, such as AP-1 (activating protein-1), NF-κB (Nuclear Factor kappa B), HIF-1α (Hypoxia-inducible factor 1-alpha), and STAT3 (Signal Transducers and Activators of Transcription 3). These factors are involved in physiological cellular processes, such as cell growth, inflammation, and angiogenesis, as well as in cancer. In human malignant tumors, APE1 overexpression is associated with lung, colon, ovaries, prostate, and breast cancer progression, more aggressive tumor phenotypes, and worse prognosis. In this review, we explore APE1 and its domain’s role in cancer development processes, highlighting the role of APE1 in the hallmarks of cancer. We reviewed original articles and reviews from Pubmed related to APE1 and cancer and found that both domains of APE1/REF-1, but mainly its redox activity, are essential to cancer cells. This protein is often overexpressed in cancer, and its expression and activity are correlated to processes such as proliferation, invasion, inflammation, angiogenesis, and resistance to cell death. Therefore, APE1 participates in essential processes of cancer development. Then, the activity of APE1/REF-1 in these hallmarks suggests that targeting this protein could be a good therapeutic approach.


  • Effects of photobiomodulation by low-power lasers and LEDs on the viability, migration, and invasion of breast cancer cells

    by Thayssa Gomes da Silva, Juliana Alves Rodrigues, Priscyanne Barreto Siqueira, Márcia dos Santos Soares, Andre Luiz Mencalha, Adenilson de Souza Fonseca

    Among the malignant tumors, breast cancer is the most commonly diagnosed worldwide, being the most prevalent in women. Photobiomodulation has been used for wound healing, swelling and pain reduction, and muscle repair. The application of photobiomodulation in cancer patients has been controversial. Therefore, a better understanding of radiation-induced effects involved in photobiomodulation on cancer cells is needed. Thus, this study aimed to investigate the effects of exposure to low-power lasers and LEDs on cell viability, migration, and invasion in human breast cancer cells. MCF-7 and MDA-MB-231 cells were irradiated with a low-power red laser (23, 46, and 69 J/cm2, 0.77 W/cm2) and blue LED (160, 321, and 482 J/cm2, 5.35 W/cm2), alone or in combination. Cell viability was assessed using the WST-1 assay, cell migration was evaluated using the wound healing assay, and cell invasion was performed using the Matrigel transwell assay. Viability and migration were not altered in MCF-7 and MDA-MB-231 cultures after exposure to low-power red laser and blue LED. However, there was a decrease in cell invasion from the cultures of the two cell lines evaluated. The results suggest that photobiomodulation induced by low-power red laser and blue LED does not alter cell viability and migration but decreases cell invasion in human breast cancer cells.


  • Top Cited Papers

    Photobiomodulation at molecular, cellular, and systemic levels

    by Thayssa Gomes da Silva, Rickson Souza Ribeiro, Andre Luiz Mencalha, Adenilson de Souza Fonseca

    Since the reporting of Endre Mester’s results, researchers have investigated the biological effects induced by non-ionizing radiation emitted from low-power lasers. Recently, owing to the use of light-emitting diodes (LEDs), the term photobiomodulation (PBM) has been used. However, the molecular, cellular, and systemic effects involved in PBM are still under investigation, and a better understanding of these effects could improve clinical safety and efficacy. Our aim was to review the molecular, cellular, and systemic effects involved in PBM to elucidate the levels of biological complexity. PBM occurs as a consequence of photon-photoacceptor interactions, which lead to the production of trigger molecules capable of inducing signaling, effector molecules, and transcription factors, which feature it at the molecular level. These molecules and factors are responsible for cellular effects, such as cell proliferation, migration, differentiation, and apoptosis, which feature PBM at the cellular level. Finally, molecular and cellular effects are responsible for systemic effects, such as modulation of the inflammatory process, promotion of tissue repair and wound healing, reduction of edema and pain, and improvement of muscle performance, which features PBM at the systemic level.